Orotidine 5'-monophosphate de
carboxylase (ODCase) has evolved to
catalyze the de
carboxylation of orotidine5'-monophosphate without any
covalent intermediates. A
ctive site residues in ODCase are involved in anextensive hydrogen-bonding network. We dis
covered that 6-iodouridine 5'-monophosphate (6-iodo-UMP)irreversibly inhibits the
catalyti
c a
ctivities of ODCases from
Methanobacterium thermoautotrophicum and
Plasmodium falciparum. Mass spe
ctral analysis of the enzyme-inhibitor
complex
confirms
covalentatta
chment of the inhibitor to ODCase a
ccompanied by the loss of two protons and the iodo moiety. TheX-ray
crystal stru
cture (1.6 Å resolution) of the
complex of the inhibitor and ODCase
clearly shows the
covalent bond formation with the a
ctive site Lys-42 residue. 6-Iodo-UMP inhibits ODCase in a time- and
con
centration-dependent fashion. 6-Iodouridine, the nu
cleoside form of 6-iodo-UMP, exhibited potentantiplasmodial a
ctivity, with IC
50s of 4.4 ± 1.3
![](/images/entities/mgr.gif)
M and 6.2 ± 0.7
![](/images/entities/mgr.gif)
M against
P. falciparum ItG and 3D7isolates, respe
ctively. 6-Iodouridine 5'-monophosphate is a novel
covalent inhibitor of ODCase, and itsnu
cleoside analogue paves the way to a new
class of inhibitors against malaria.